1928 Diagnostics was founded by four scientists and entrepreneurs within tech and healthcare to contribute in the combat against one of the greatest threats facing humanity - antibiotic resistance. Since the foundation of the company in 2014, we have commercialized Professor Erik Kristiansson's research at Chalmers University of technology, Sweden, into a DNA analytics platform for healthcare providers to effectively track and minimize spread of superbugs globally. Long-term friends Dr. Kristina Lagerstedt and Dr. Susanne Staaf, with medical and big-pharma backgrounds, have operated 1928 Diagnostics together from day one and built the team of software developers, bioinformaticians, microbiologists and quality engineers who together have built the 1928 platform. The 1928 Diagnostics Chairman of the Board- tech and medtech serial entrepreneur, Olof Sköld, has guided the team based on his wide experiences and built a globally operating and recognized company with a clear vision. The strength of the 1928 Diagnostics team is our faceted competence, our continuous and strong relations within tech, healthcare and science and most of all - our common goal. We are dedicated and convinced that by collaboration and bridging innovative technology we can and will contribute to world health.
1928 Diagnostics is a growing team of bioinformaticians, software developers, microbiologists and molecular biologists dedicated to enable and optimize the use of the powerful whole genome sequencing technology to improve infection diagnostics worldwide. By developing a full service in close contact and collaboration with end users we build an easy-to-use and highly powerful bioinformatic analysis platform that fill present and future needs of infection control.
Kristina has a clinical research background from Sahlgrenska University hospital where she focused on diagnostic markers and personalized healthcare. She has an excellence in cell and molecular biology and genetics and has multiple experience in commercialisation activities of academic research.
Fredrik is an experienced team lead and software developer with expert domain knowledge in web development and cloud technologies.
Fanny holds a BSc in Biotechnology, and a MSc in Business Design from Chalmers Schools of Entrepreneurship. During her career she has worked globally with sales and business development at both small and large companies within the Medtech industry.
Pernilla has long experience from administration, management and HR in addition to being the face forward in communicative roles for large organizations in both Sweden and the US.
Dimitris is a bioinformatician with past experience in analyzing metagenomic and population genomic data.
Oscar is a bioinformatician with a MSc in Biotechnology. He focuses on long read sequencing data analysis.
Majken is a developer with a background in astrophysics. She has previous experience in data science, building numerical and analytical models, project management and public relations.
Karl Johan is an experienced software developer with expert domain knowledge in system architecture and automation.
Emil is a bioinformatician and molecular biologist with specialization in RNA-seq analysis and pipeline development.
Elin is a developer with a background in software engineering and algorithms. She has previous experience in web development and her main focus is the frontend and user experience.
Erik is a bioinformatician and molecular biologist with a past in producing and analyzing phenomics data.
Olof has 15 years experience of building international companies in the Life Science and IT sectors. As a previous CEO of Denator he built sales force and distributional network in over 20 countries.
Erik has excellence in mathematical statistics and is an expert in analysis of large-scale data from next generation DNA sequencing. He leads a research group at Chalmers University of Technology focusing on analysis of quantitative data with applications in molecular biology and medicine.
Kristina has a clinical research background from Sahlgrenska University hospital where she focused on diagnostic markers and personalized healthcare. She has an excellence in cell and molecular biology and genetics and has multiple experience in commercialisation activities of academic research.
Michelle has over 15 years of experience as an business investor and has extensive experience being member of a board of directors for various companies in the health care, consumer and TMT sectors.
Gunnar is an authority in the field of antibiotic resistance. He was President of EUCAST, European Committee on Antimicrobial Susceptibility Testing, a position he has held for 11 years. In addition to that has been Head of the Clinical microbiology department at the county of Kronoberg for over 30 years.
Do you want to participate in the fight against antibiotic resistant bacteria? Join our dynamic development team and make a difference!
Click here to go to the jobs page.